RLAY vs SBUX · rev $3.4M vs P/E 76, rev $37.18B
Relay Therapeutics Inc (RLAY) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
RLAY currently screens at market cap $3.39B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the RLAY and SBUX stock pages for the full models.
Not investment advice.